MedPath

Implantation of Porous Titanium Prosthesis in Laryngeal Surgery

Phase 2
Conditions
Vocal Cord Paralysis
Registration Number
NCT00213863
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

This study evaluates a medialization implant to treat vocal cord paralysis, to permit it to adjust the quality of the voice under local or general anesthesia. The aim is to restore phonation using a porous titanium prosthesis in laryngeal surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Males or females greater than 18 years old
Exclusion Criteria
  • Age less than 18 years
  • Pregnant women
  • Local carcinoma excluding radiotherapeutic or surgical control
  • Bad general condition
  • Contraindication to general anesthesia
  • Non-controlled diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Nasofibroscopy8 days and 3 months after surgery
Voice control and recording8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
All types of complication8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre

🇫🇷

Strasbourg, France

Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre
🇫🇷Strasbourg, France
Christian Debry, MD
Contact
33.3.88.12.76.45
christian.debry@chru-strasbourg.fr
Christian DEBRY, MD
Principal Investigator
Philippe SCHULTZ, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.